Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Sabby Management Joins Alpha Capital Anstalt in DARA Biosciences With 8.3% Stake

Sabby Management, Dara Biosciences: In a new 13G filing just reported to the SEC, Hal Mintz’s Sabby Management reported an 8.3% stake in DARA Biosciences Inc (NASDAQ:DARA) stock. Due to the nature of the disclosure, Sabby is here as a passive investor, much as Alpha Capital Anstalt reported yesterday. At market close, Alpha reported a slightly smaller 7.6% stake in Dara.

Dara Biosciences

A couple of days earlier, Dara Biosciences announced it is entering into a Securities Purchase Agreement with several institutional investors, in which the company intends to sell 5.1 million shares in a direct offering. The price of the offering is set at $0.50 per share with gross proceeds amounting to almost $2.6 million, Dara Biosciences said in a statement.

Disclosure: none

Recommended Reading:

Hirzel Capital Just Bought More Hawaiian Holdings Stock at $7.40/Share

Solus Alternative Asset Management Sells Some YRC Worldwide

How Warren Buffett’s ‘LeBron James Analogy’ Could Make You A Fortune


DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.